Home Newsfeeds Redburn Partners Initiates Coverage On Nasdaq with Neutral Rating

Redburn Partners Initiates Coverage On Nasdaq with Neutral Rating

Redburn Partners analyst Michael Cyprys initiates coverage on Nasdaq (NASDAQ:NDAQ) with a Neutral rating.

byBenzinga Newsdesk

November 14, 2022

1 minute read

Redburn Partners analyst Michael Cyprys initiates coverage on Nasdaq (NASDAQ:NDAQ) with a Neutral rating.

Florida Rep. Scott Franklin Sold Over $50K Worth of Cisco Systems Stock: Here’s What You Should Know

By Benzinga Insights

October 13, 11:05 AM

Representative Scott Franklin from Florida reported a sale of Cisco Systems (NASDAQ:CSCO) stock, according to a October filing.…

CSCO

Puma Biotechnology Sees Q2 Net Product Revenue $43M-$45M; FY24 Net Product Revenue $183M-$190M

By Benzinga Newsdesk

May 2, 5:59 PM

Second Quarter and Full Year 2024 Financial Outlook Second Quarter 2024Full Year 2024Net Product Revenue$43 -45 million$183 - $190 millionRoyalty Revenue$2.5 - $3 million$30 - $33 millionLicense Revenue$0 million$1

PBYI

Sam Adams Maker Ventures Into Cannabis Iced Tea: What’s Brewing In This New Venture?

By Nicolas Jose Rodriguez

November 1, 4:22 PM

The Boston Beer Company, Inc. (NYSE: SAM), known for brands like Sam Adams and Twisted Tea, entered the cannabis beverage market

SAM

B of A Securities Maintains Buy on Intl Flavors & Fragrances, Lowers Price Target to $161

By Benzinga Newsdesk

July 13, 11:46 AM

B of A Securities analyst Matthew DeYoe maintains Intl Flavors & Fragrances (NYSE:IFF) with a Buy and lowers the price target from $169 to $161.

IFF

Redburn Partners Initiates Coverage On Nasdaq with Neutral Rating

Related Posts

Florida Rep. Scott Franklin Sold Over $50K Worth of Cisco Systems Stock: Here’s What You Should Know

Puma Biotechnology Sees Q2 Net Product Revenue $43M-$45M; FY24 Net Product Revenue $183M-$190M

Sam Adams Maker Ventures Into Cannabis Iced Tea: What’s Brewing In This New Venture?

B of A Securities Maintains Buy on Intl Flavors & Fragrances, Lowers Price Target to $161